Condition category
Mental and Behavioural Disorders
Date applied
30/09/2005
Date assigned
23/11/2005
Last edited
27/06/2017
Prospective/Retrospective
Prospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof Tamsin Ford

ORCID ID

http://orcid.org/0000-0001-5295-4904

Contact details

Room 2.05c
University of Exeter Medical School
South Cloisters
St Luke's Campus
Exeter
EX1 2LU
United Kingdom
+44 1392 722 973
T.J.Ford@exeter.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

The utility of pre-assessment standardised diagnosis in child and adolescent mental health services

Acronym

Study hypothesis

1. Are the clinical assessments more likely to agree with the standardized diagnosis if the clinician has had access to the standardized diagnosis prior to the first appointment with the family?
2. Are the children more likely to receive an evidence-based treatment if the clinician has access to the standardized diagnosis prior to the first appointment with the family?
3. Are children able to access specialist clinics if clinicians/managers are aware of the diagnostic assessment?
4. Is the level of agreement between the clinical and standardized diagnoses higher in the last six months of the study compared to the first, suggesting that the clinical team is learning from their exposure to the standardized assessments?
5. Do clinicians find the information provided by the standardized diagnosis useful in making their own assessment?
6. Is the rate of attendance at first appointments higher among children whose parents have completed a standardized diagnostic assessment while on the waiting list as compared to control children?
7. Do parents find the completion of a standardized assessment prior to meeting the clinician useful and/or acceptable?

Ethics approval

Joint South London and Maudsley and Institute of Psychiatry Research Ethics Committee, 14/09/2005, ref: 05/Q0706/185

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Not specified

Trial type

Not Specified

Patient information sheet

See additional files

Condition

Childhood psychiatric disorders

Intervention

Current interventions as of 27/06/2017:
Practitioners assessing and treating children in the intervention were provided with a copy of the standardised diagnostic assessment (the DAWBA www.dawba.info) in the clinic notes – children in the control arm had assessment and treatment as normal – follow up was by questionnaire to the treating CAMHS practitioner and parents at six, 12, 18 and 24 months after baseline – obviously practitioners could only report while the child was still attending the clinic.

Previous interventions:
The intervention would be the provision of diagnostic information to the intervention group, while the control group would undergo the ordinary clinic assessment. The diagnostic information will be gathered from parents and teachers using the Development And Well-Being Assessment (DAWBA).

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

The primary outcome measures will be the level of agreement between the DAWBA diagnoses and the clinical assessment, and the type of intervention. After the assessment, clinicians will be asked to report which diagnoses they endorse, including no disorder or none of the above, using a pro forma listing the disorders described by the DAWBA. At six months or case closure, the clinicians will describe the type of intervention using a second structured pro forma, which will be based on the categories available on those used in the proposed national minimum data set for child and adolescent mental health services.

Secondary outcome measures

Secondary outcome measures will be parental and clinician measures of outcome, parents and clinicians opinion of the utility of the standardized assessment, the number of appointments attended and the non-attendance rates of the two groups. The latter is collected routinely by the clinic. Questionnaires using a combination of structured and unstructured questionnaires will address the utility of the standardized assessment from the perspective of parents and clinicians. The outcome measures are the Strengths and Difficulties Questionnaire (SDQ), which will be completed by parents, and the Child Global Assessment Scale (CGAS), which will be completed by parents.

Overall trial start date

01/10/2004

Overall trial end date

30/09/2011

Reason abandoned

Eligibility

Participant inclusion criteria

The trial will include all referrals to Croydon child and adolescent mental health service of children aged between 5-11 years of age who are accepted onto the waiting list.

Participant type

Patient

Age group

Child

Gender

Both

Target number of participants

Target number of participants provided at time of registration: 520; Amended as of 14/02/2007: 500 children, 250 in each arm

Participant exclusion criteria

Children of parents with insufficient English to complete the assessment interview and emergency referrals will be excluded due to the difficulty in completing the standardized assessment. Due to the complexity of parental responsibility and therefore gaining consent, children looked after by the local authority will be excluded.

Recruitment start date

01/03/2006

Recruitment end date

31/05/2008

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Croydon CAMHS (Lead site)
Lennard Lodge Lennard Road
Croydon
CR0 2UL
United Kingdom

Sponsor information

Organisation

King's College London (UK)

Sponsor details

Institute of Psychiatry
De Crespigny Park
London
SE5 8AF
United Kingdom
+44 20 7848 0675
G.Dale@iop.kcl.ac.uk

Sponsor type

University/education

Website

Funders

Funder type

Research council

Funder name

Medical Research Council (MRC) (UK)

Alternative name(s)

MRC

Funding Body Type

government organisation

Funding Body Subtype

Federal/National Government

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Planned publication in high-impact peer reviewed journals.

IPD sharing statement:
The datasets generated during and/or analysed during the current study is not expected to be made available due to they do not have appropraite consent for this.

Intention to publish date

Participant level data

Not expected to be available

Results - basic reporting

Publication summary

2013 results in https://www.ncbi.nlm.nih.gov/pubmed/22886389
2013 results in http://onlinelibrary.wiley.com/doi/10.1111/camh.2014.19.issue-2/issuetoc

Publication citations

Additional files

Editorial Notes

27/06/2017: Study contact title changed from Dr to Professor and institution changed from Department of Child and Adolescent Psychiatry Institute of Psychiatry KCL to University of Exeter Medical School. Publication references added. Trial dates have been updated from 20/01/2006 - 11/09/2010 to 01/10/2004 - 30/09/2011. Recruitment dates have been updated from 20/01/2006- 11/09/2010 to 01/03/2006 - 31/05/2008. Added Croydon CAMHS and Bromley CAMHS as trial participating sites. Added participant level data sharing statement. ORCID was added. 12/07/2016: No publications found, verifying study status with principal investigator.